MA42964A - Préparation pharmaceutique anti-vieillissement - Google Patents
Préparation pharmaceutique anti-vieillissementInfo
- Publication number
- MA42964A MA42964A MA042964A MA42964A MA42964A MA 42964 A MA42964 A MA 42964A MA 042964 A MA042964 A MA 042964A MA 42964 A MA42964 A MA 42964A MA 42964 A MA42964 A MA 42964A
- Authority
- MA
- Morocco
- Prior art keywords
- pharmaceutical preparation
- aging pharmaceutical
- aging
- preparation
- pharmaceutical
- Prior art date
Links
- 230000003712 anti-aging effect Effects 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16001807 | 2016-08-17 | ||
PCT/EP2016/001887 WO2017080668A1 (fr) | 2015-11-13 | 2016-11-14 | Préparation pharmaceutique efficace contre les troubles liés au vieillissement |
PCT/EP2016/001888 WO2017080669A1 (fr) | 2015-11-13 | 2016-11-14 | Préparation pharmaceutique efficace contre les troubles liés au vieillissement |
Publications (1)
Publication Number | Publication Date |
---|---|
MA42964A true MA42964A (fr) | 2018-08-01 |
Family
ID=61196401
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA042963A MA42963A (fr) | 2016-08-17 | 2017-05-11 | Préparation pharmaceutique anti-vieillissement |
MA042964A MA42964A (fr) | 2016-08-17 | 2017-05-12 | Préparation pharmaceutique anti-vieillissement |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA042963A MA42963A (fr) | 2016-08-17 | 2017-05-11 | Préparation pharmaceutique anti-vieillissement |
Country Status (21)
Country | Link |
---|---|
US (3) | US20190290689A1 (fr) |
EP (4) | EP3695845A1 (fr) |
JP (2) | JP2019528281A (fr) |
KR (2) | KR20190049690A (fr) |
CN (2) | CN108348548A (fr) |
AU (2) | AU2017313163B2 (fr) |
BR (2) | BR112019002080A2 (fr) |
CA (2) | CA3033045A1 (fr) |
CL (2) | CL2019000420A1 (fr) |
CO (2) | CO2019001232A2 (fr) |
CR (2) | CR20190139A (fr) |
EA (2) | EA201890841A1 (fr) |
HK (3) | HK1255619A1 (fr) |
IL (2) | IL259007B1 (fr) |
MA (2) | MA42963A (fr) |
MX (2) | MX2019001948A (fr) |
PE (2) | PE20190627A1 (fr) |
PH (2) | PH12019550017A1 (fr) |
SG (2) | SG11201900866YA (fr) |
TW (2) | TW201806606A (fr) |
WO (3) | WO2018033226A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2017313163B2 (en) * | 2016-08-17 | 2019-01-03 | Orthogen Ag | Anti-ageing pharmaceutical preparation |
CN108841784A (zh) * | 2018-07-17 | 2018-11-20 | 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 | 一种含黄芪甲苷的髓核细胞抗衰老抗凋亡培养基 |
EP3613424A1 (fr) * | 2018-08-23 | 2020-02-26 | Orthogen AG | Nouveaux procédés pour la production d'agents pharmaceutiques |
KR20210109556A (ko) * | 2018-12-27 | 2021-09-06 | 산토리 홀딩스 가부시키가이샤 | 변성 엘라스틴의 분해 저하의 억제제, 정상적인 엘라스틴 섬유의 유지제, 엘라스틴-엘라핀 복합체 형성 억제제 및 엘라스틴-엘라핀 복합체 형성 억제 작용을 갖는 물질의 스크리닝 방법 |
RU2695264C1 (ru) * | 2018-12-27 | 2019-07-22 | федеральное государственное бюджетное образовательное учреждение высшего образования "Хакасский государственный университет им. Н.Ф. Катанова" (ФГБОУ ВО ХГУ им. Н.Ф. Катанова) | Способ прогнозирования ускоренного старения организма женщин, основанный на клинических данных о состоянии репродуктивной функции |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0512814A (pt) * | 2004-07-01 | 2008-04-08 | Univ Pittsburgh Of The Commmmo | exosomas imunossupressivas |
DE102006005016A1 (de) * | 2006-02-03 | 2007-08-16 | Orthogen Ag | Konditionierte Blutzusammensetzung und Verfahren zu deren Herstellung |
DE202009017772U1 (de) * | 2009-12-10 | 2011-04-21 | Orthogen Ag | Kombinationspräparate mit Cytokin-Antagonist und Corticosteroid |
WO2012076193A1 (fr) * | 2010-12-10 | 2012-06-14 | Orthogen Ag | Préparations combinées contenant des exosomes et un corticostéroïde |
EP2882445B1 (fr) * | 2012-08-13 | 2019-04-24 | Cedars-Sinai Medical Center | Exosomes et acides micro-ribonucléiques pour la régénération de tissus |
DE102012019088A1 (de) * | 2012-09-28 | 2014-04-03 | Orthogen Ag | Antibakterielle Arzneimittelpräparate |
CN103767985A (zh) * | 2012-10-22 | 2014-05-07 | 吉林省霍普金斯药物研究院有限责任公司 | 人源血液或间充质干细胞分泌exosome的制备与应用 |
KR101784050B1 (ko) * | 2014-12-23 | 2017-10-10 | 영남대학교 산학협력단 | 엑소솜을 유효성분으로 함유하는 피부 노화 예방 또는 치료용 약학조성물 |
CN105477016A (zh) * | 2015-11-13 | 2016-04-13 | 中国人民解放军第二军医大学 | 人间充质干细胞来源的外泌体在抗组织纤维化及瘢痕形成中的应用 |
WO2017080669A1 (fr) * | 2015-11-13 | 2017-05-18 | Orthogen Ag | Préparation pharmaceutique efficace contre les troubles liés au vieillissement |
CN105505854B (zh) * | 2016-01-14 | 2019-07-12 | 上海市第六人民医院 | 来源于人尿液细胞的外泌体的获取方法与应用 |
CN105582576B (zh) * | 2016-02-23 | 2018-08-17 | 武汉大复生物科技有限公司 | 提高内皮祖细胞外泌体释放并促进骨缺损修复的生物材料、制备方法及用途 |
AU2017313163B2 (en) * | 2016-08-17 | 2019-01-03 | Orthogen Ag | Anti-ageing pharmaceutical preparation |
-
2017
- 2017-05-11 AU AU2017313163A patent/AU2017313163B2/en active Active
- 2017-05-11 CA CA3033045A patent/CA3033045A1/fr active Pending
- 2017-05-11 IL IL259007A patent/IL259007B1/en unknown
- 2017-05-11 MX MX2019001948A patent/MX2019001948A/es unknown
- 2017-05-11 US US16/325,870 patent/US20190290689A1/en not_active Abandoned
- 2017-05-11 JP JP2019508969A patent/JP2019528281A/ja active Pending
- 2017-05-11 SG SG11201900866YA patent/SG11201900866YA/en unknown
- 2017-05-11 MA MA042963A patent/MA42963A/fr unknown
- 2017-05-11 EP EP20155846.7A patent/EP3695845A1/fr active Pending
- 2017-05-11 EA EA201890841A patent/EA201890841A1/ru unknown
- 2017-05-11 CR CR20190139A patent/CR20190139A/es unknown
- 2017-05-11 CN CN201780003804.9A patent/CN108348548A/zh active Pending
- 2017-05-11 BR BR112019002080-2A patent/BR112019002080A2/pt unknown
- 2017-05-11 PE PE2019000304A patent/PE20190627A1/es not_active Application Discontinuation
- 2017-05-11 WO PCT/EP2017/000574 patent/WO2018033226A1/fr active Application Filing
- 2017-05-11 EP EP17728051.8A patent/EP3352769A1/fr not_active Withdrawn
- 2017-05-11 KR KR1020197003441A patent/KR20190049690A/ko not_active Application Discontinuation
- 2017-05-12 KR KR1020197004442A patent/KR20190046793A/ko unknown
- 2017-05-12 AU AU2017313164A patent/AU2017313164B2/en active Active
- 2017-05-12 TW TW106115816A patent/TW201806606A/zh unknown
- 2017-05-12 PE PE2019000361A patent/PE20190517A1/es not_active Application Discontinuation
- 2017-05-12 JP JP2019508931A patent/JP2019529357A/ja active Pending
- 2017-05-12 EA EA201890840A patent/EA201890840A1/ru unknown
- 2017-05-12 BR BR112019002982-6A patent/BR112019002982A2/pt not_active Application Discontinuation
- 2017-05-12 US US16/325,945 patent/US20210290671A1/en not_active Abandoned
- 2017-05-12 WO PCT/EP2017/000581 patent/WO2018033227A1/fr active Application Filing
- 2017-05-12 CR CR20190091A patent/CR20190091A/es unknown
- 2017-05-12 EP EP17728052.6A patent/EP3352770A1/fr not_active Withdrawn
- 2017-05-12 MA MA042964A patent/MA42964A/fr unknown
- 2017-05-12 MX MX2019001949A patent/MX2019001949A/es unknown
- 2017-05-12 SG SG11201901085RA patent/SG11201901085RA/en unknown
- 2017-05-12 CN CN201780003805.3A patent/CN108348549A/zh active Pending
- 2017-05-12 EP EP20163717.0A patent/EP3763377A1/fr active Pending
- 2017-05-12 CA CA3033899A patent/CA3033899A1/fr not_active Abandoned
- 2017-05-12 TW TW106115815A patent/TW201806605A/zh unknown
- 2017-08-17 US US16/325,944 patent/US20190231816A1/en not_active Abandoned
- 2017-08-17 WO PCT/EP2017/000994 patent/WO2018033249A1/fr active Application Filing
-
2018
- 2018-04-29 IL IL259006A patent/IL259006A/en unknown
- 2018-11-19 HK HK18114754.7A patent/HK1255619A1/zh unknown
-
2019
- 2019-01-22 HK HK19101113.9A patent/HK1258712A1/zh unknown
- 2019-01-22 HK HK19101111.1A patent/HK1259143A1/zh unknown
- 2019-01-30 PH PH12019550017A patent/PH12019550017A1/en unknown
- 2019-02-08 PH PH12019550022A patent/PH12019550022A1/en unknown
- 2019-02-12 CO CONC2019/0001232A patent/CO2019001232A2/es unknown
- 2019-02-13 CO CONC2019/0001265A patent/CO2019001265A2/es unknown
- 2019-02-15 CL CL2019000420A patent/CL2019000420A1/es unknown
- 2019-02-15 CL CL2019000419A patent/CL2019000419A1/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3529248T3 (da) | Farmaceutiske sammensætninger | |
DK3328880T3 (da) | Terapeutiske midler | |
DK3236943T3 (da) | Sammensætninger til ileo-jejunal lægemiddeladministration | |
DK3253382T3 (da) | Farmaceutiske sammensætninger til kombinationsterapi | |
DK3479819T3 (da) | Stabilt væskeformigt farmaceutisk præparat | |
BR112016023628A2 (pt) | composições farmacêuticas. | |
DK3089741T3 (da) | Farmaceutiske sammensætninger omfattende azd9291 | |
MA46334A (fr) | Composition pharmaceutique liquide | |
DK3529240T3 (da) | Farmaceutiske forbindelser | |
DK3532029T3 (da) | Flydende farmaceutisk sammensætning | |
DK3261951T3 (da) | Pakkestruktur til beholdere til farmaceutisk anvendelse | |
MA43705A (fr) | Formulation pharmaceutique | |
MA42964A (fr) | Préparation pharmaceutique anti-vieillissement | |
DK3199161T3 (da) | Farmaceutisk præparat | |
DK3634377T3 (da) | Farmaceutisk formulering | |
MA42840A (fr) | Composé pharmaceutique | |
ES2841649T5 (es) | Composición farmacéutica | |
MA47516A (fr) | Composition pharmaceutique | |
DK3463345T3 (da) | Farmaceutiske kombinationer | |
BR112017013012A2 (pt) | compostos de indenil, composições farmacêuticas e usos médicos destes | |
MA44987A (fr) | Formulations de médicaments améliorées | |
MA52704A (fr) | Préparation pharmaceutique | |
DK3280447T3 (da) | Farmaceutiske formuleringer | |
DK3601277T3 (da) | Farmaceutisk formulering | |
MA45126A (fr) | Formulation pharmaceutique antifongique |